Brinker Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-17,727
Closed -$587K 976
2019
Q2
$587K Sell
17,727
-1,186
-6% -$40.6K 0.02% 647
2019
Q1
$663K Buy
18,913
+1,511
+9% +$56.2K 0.03% 593
2018
Q4
$578K Buy
17,402
+1,379
+9% +$59.3K 0.03% 560
2018
Q3
$807K Buy
16,023
+1,166
+8% +$57.6K 0.03% 558
2018
Q2
$889K Buy
14,857
+926
+7% +$48K 0.03% 520
2018
Q1
$638K Buy
13,931
+640
+5% +$26.7K 0.03% 629
2017
Q4
$530K Sell
13,291
-584
-4% -$23.1K 0.02% 670
2017
Q3
$555K Buy
13,875
+1,651
+14% +$71.5K 0.02% 639
2017
Q2
$527K Buy
12,224
+532
+5% +$18.9K 0.02% 515
2017
Q1
$366K Buy
11,692
+420
+4% +$11.3K 0.02% 714
2016
Q4
$285K Buy
+11,272
New +$252K 0.02% 594

Other funds holding SUPN